Question: Blood-based plasma biomarkers for AD screening

Plasma Aβ42/40 ratio cutoff for amyloid burden

Needs new evidence

1/5 publication-ready

4 verified (technical) Lab Board · 3

Findings metrics

—

total

—

verified

—

pending

—

rejected

Research